Back to Results

AMREP Corporation (AXR)

AMREP Corporation is a U.S. real estate company listed on the NYSE under the ticker AXR. Through its subsidiaries, the company operates in two segments: Land Development and Homebuilding. Its land development activities include planning and preparing property for development, securing government and environmental approvals, arranging utilities and storm drainage, supporting road construction and community infrastructure, and providing landscaping services to homebuilders. AMREP also acquires land and sells developed and undeveloped lots to homebuilders, as well as to commercial and industrial property developers through brokers. In addition, the company builds and sells single-family detached homes and attached homes, including built-to-order homes and a range of floor plans and elevations. AMREP also owns mineral and mineral rights across approximately 55,000 surface acres in Sandoval County, New Mexico. The company was incorporated in 1955 and is based in Havertown, Pennsylvania.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-AXR
$25.84
1.3% Upside
Fair
$30
17.6% Upside
Fair
Great
—
—
—
0.0%
July 28, 2026
10.4x
1.0x
2.5x
134.4 M
84.439 M
0.0%
52.9%
20.3
—
101.4%
Valuation • Fair Value

AMREP Corporation (NYSE-AXR) Fair Value by Valuation Model

Compare the primary fair value estimate for AMREP Corporation (NYSE-AXR) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$25.84

Estimated upside of 1.3% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$29.12

Discounted cash flow valuation reference.

Ben Graham Formula Value

$27.22

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$30.15

Earnings power value estimate.

Comps Fair Value

$21.84

Comparable-company valuation reference.

Analyst Price Target

$30

Analysts imply upside of 17.6%.

How to read these valuation models

Use this section to compare the primary fair value estimate for AMREP Corporation (NYSE-AXR) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for AMREP Corporation (NYSE-AXR)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

53.001 M

Current operating scale indicator.

Revenue Forecast

54.18 M

Forward revenue estimate.

EBITDA

14.109 M

Current operating profitability reference.

EBITDA Forecast

13.22 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review AMREP Corporation (NYSE-AXR) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for AMREP Corporation (NYSE-AXR)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

NM

Forensic accounting screen.

Altman Z-Score

20.3

Relatively strong balance-sheet zone.

FCF / Net Income

101.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for AMREP Corporation (NYSE-AXR). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for AMREP Corporation (NYSE-AXR)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 28, 2026

Days to Earnings

7

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for AMREP Corporation (NYSE-AXR), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

AMREP Corporation (NYSE-AXR) Stock Forecast & Technical Outlook

Review AMREP Corporation (NYSE-AXR) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for AMREP Corporation (NYSE-AXR) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for AMREP Corporation (NYSE-AXR) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for AMREP Corporation (NYSE-AXR) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for AMREP Corporation (NYSE-AXR) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for AMREP Corporation (NYSE-AXR) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for AMREP Corporation (NYSE-AXR)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, AMREP Corporation (NYSE-AXR) has a Hold consensus, with 0 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 1
Sell 0
FAQ • Fast Investor Answers

AMREP Corporation (NYSE-AXR) Stock FAQ

Quick answers about AMREP Corporation (NYSE-AXR) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$25.84
Estimated upside 1.3%
Valuation Rating
Near Fair Value
Price is close to fair value
Analyst Target
$30
Implied upside 17.6%
Financial Health
Great
Current financial-health read

The current fair value estimate for AMREP Corporation (NYSE-AXR) is $25.84. This implies an estimated upside of 1.3% versus the current market price.

Based on the current fair value estimate, the stock is trading close to its estimated fair value.

The available analyst price target for AMREP Corporation (NYSE-AXR) is $30. The analyst target implies estimated upside of 17.6%.

The current financial health read for AMREP Corporation (NYSE-AXR) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for AMREP Corporation (NYSE-AXR) is July 28, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for AMREP Corporation (NYSE-AXR) is 10.4x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for AMREP Corporation is 134.4 M.

The current enterprise value listed for AMREP Corporation is 84.439 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for AMREP Corporation is NYSE-AXR, and the stock is listed on NYSE.

AMREP Corporation (NYSE-AXR) is listed on NYSE.

The current debt-to-total-capital ratio listed for AMREP Corporation is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for AMREP Corporation is 52.9%. Free float helps investors understand how much of the share base is available for public trading.

Similar Real Estate Management & Development Stocks on NYSE View more

CBRE Group Inc Class A (CBRE) CBRE Group Inc Class A (CBRE)
Ke Holdings Inc (BEKE) Ke Holdings Inc (BEKE)
Jones Lang LaSalle Incorporated (JLL) Jones Lang LaSalle Incorporated (JLL)
Compass Inc (COMP) Compass Inc (COMP)
LandBridge Co LLC (LB) LandBridge Co LLC (LB)
Howard Hughes Holdings Inc (HHH) Howard Hughes Holdings Inc (HHH)
St Joe Company (JOE) St Joe Company (JOE)
Vesta Real Estate Corporation SAB de CV ADR (VTMX) Vesta Real Estate Corporation SAB de CV ADR (VTMX)
Cushman & Wakefield plc (CWK) Cushman & Wakefield plc (CWK)
Forestar Group Inc (FOR) Forestar Group Inc (FOR)
IRSA Inversiones Y Representaciones (IRS) IRSA Inversiones Y Representaciones (IRS)
Marcus & Millichap Inc (MMI) Marcus & Millichap Inc (MMI)
Five Point Holdings LLC (FPH) Five Point Holdings LLC (FPH)
Tejon Ranch Co (TRC) Tejon Ranch Co (TRC)
Transcontinental Realty Investors (TCI) Transcontinental Realty Investors (TCI)
Re Max Holding (RMAX) Re Max Holding (RMAX)
Seaport Entertainment Group Inc (SEG) Seaport Entertainment Group Inc (SEG)
Maui Land & Pineapple Company Inc (MLP) Maui Land & Pineapple Company Inc (MLP)
American Realty Investors Inc (ARL) American Realty Investors Inc (ARL)
New England Realty Associates LP (NEN) New England Realty Associates LP (NEN)
Belpointe PREP LLC Unit (OZ) Belpointe PREP LLC Unit (OZ)
Douglas Elliman Inc (DOUG) Douglas Elliman Inc (DOUG)
Seritage Growth Properties (SRG) Seritage Growth Properties (SRG)
Seritage Growth Properties Pref Series A (SRG_pa) Seritage Growth Properties Pref Series A (SRG_pa)